Correction: Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor signaling and prostate cancer progression
Haolong Li, Ning Xie, Martin E. Gleave, Xuesen Dong
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsProstate Cancer Treatment and Research · Cancer therapeutics and mechanisms · Ubiquitin and proteasome pathways
This article has been corrected: Oncotarget has investigated concerns regarding duplicate images in this paper. In Figure 3, the tubulin band in panel 3D is a duplicate of the H3 band in panel 3C. Additionally, the Actin band is a duplicate of one shown in Figure 4C of an earlier article that includes two authors in common with the Oncotarget paper [1]. We also found duplication in Supplementary Figure 1 (AR-V7 western blot of three LANCaP cell lines) which overlaps with WB band in Figure 7C of [1]. The corresponding author of both these articles, Dr. Xuesen Dong, has stated: “The reason for these mistakes was that Dr. Haolong Li had been working on two publications (Oncotarget and Cell Death and Disease) at the same time. Each project involved a large amount of western blotting assays; all images for the loading controls look very similar and were easily misplaced. Regardless, these minor mistakes did not affect the conclusion we have drawn.” The authors provided original western blots with date stamps for the corrected figures and stated that Figure 3A Actin (2 h treatment), Figure 3D Tubulin (second panel, 293T cells transfected with plasmid encoding AR(F876L) and Supplementary Figure 1 AR-V7 blot were misplaced during the figure assembly. The corrected Figure 3 and Supplementary Figure 1, obtained using the original data, are shown below. The authors declare that these corrections do not change the results or conclusions of this paper.
Original article: Oncotarget. 2015; 6:20474–20484. 20474-20484. https://doi.org/10.18632/oncotarget.4105
The reference list from the paper itself. Each links out to its DOI / PubMed record.